Cargando…
Risk and Protective Factors for Sudden Cardiac Death: An Umbrella Review of Meta-Analyses
BACKGROUND: Sudden cardiac death (SCD) is a global public health issue, accounting for 10–20% of deaths in industrialized countries. Identification of modifiable risk factors may reduce SCD incidence. METHODS: This umbrella review systematically evaluates published meta-analyses of observational and...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9246322/ https://www.ncbi.nlm.nih.gov/pubmed/35783841 http://dx.doi.org/10.3389/fcvm.2022.848021 |
_version_ | 1784738945414725632 |
---|---|
author | Tsartsalis, Dimitrios Korela, Dafni Karlsson, Lars O. Foukarakis, Emmanouil Svensson, Anneli Anastasakis, Aris Venetsanos, Dimitrios Aggeli, Constantina Tsioufis, Costas Braunschweig, Frieder Dragioti, Elena Charitakis, Emmanouil |
author_facet | Tsartsalis, Dimitrios Korela, Dafni Karlsson, Lars O. Foukarakis, Emmanouil Svensson, Anneli Anastasakis, Aris Venetsanos, Dimitrios Aggeli, Constantina Tsioufis, Costas Braunschweig, Frieder Dragioti, Elena Charitakis, Emmanouil |
author_sort | Tsartsalis, Dimitrios |
collection | PubMed |
description | BACKGROUND: Sudden cardiac death (SCD) is a global public health issue, accounting for 10–20% of deaths in industrialized countries. Identification of modifiable risk factors may reduce SCD incidence. METHODS: This umbrella review systematically evaluates published meta-analyses of observational and randomized controlled trials (RCT) for the association of modifiable risk and protective factors of SCD. RESULTS: Fifty-five meta-analyses were included in the final analysis, of which 31 analyzed observational studies and 24 analyzed RCTs. Five associations of meta-analyses of observational studies presented convincing evidence, including three risk factors [diabetes mellitus (DM), smoking, and early repolarization pattern (ERP)] and two protective factors [implanted cardiac defibrillator (ICD) and physical activity]. Meta-analyses of RCTs identified five protective factors with a high level of evidence: ICDs, mineralocorticoid receptor antagonist (MRA), beta-blockers, and sodium-glucose cotransporter-2 (SGLT-2) inhibitors in patients with HF. On the contrary, other established, significant protective agents [i.e., amiodarone and statins along with angiotensin-converting enzyme (ACE) inhibitors in heart failure (HF)], did not show credibility. Likewise, risk factors as left ventricular ejection fraction in HF, and left ventricular hypertrophy, non-sustain ventricular tachycardia, history of syncope or aborted SCD in pediatric patients with hypertrophic cardiomyopathy, presented weak or no evidence. CONCLUSIONS: Lifestyle risk factors (physical activity, smoking), comorbidities like DM, and electrocardiographic features like ERP constitute modifiable risk factors of SCD. Alternatively, the use of MRA, beta-blockers, SGLT-2 inhibitors, and ICD in patients with HF are credible protective factors. Further investigation targeted in specific populations will be important for reducing the burden of SCD. SYSTEMATIC REVIEW REGISTRATION: https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42020216363, PROSPERO CRD42020216363. |
format | Online Article Text |
id | pubmed-9246322 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-92463222022-07-01 Risk and Protective Factors for Sudden Cardiac Death: An Umbrella Review of Meta-Analyses Tsartsalis, Dimitrios Korela, Dafni Karlsson, Lars O. Foukarakis, Emmanouil Svensson, Anneli Anastasakis, Aris Venetsanos, Dimitrios Aggeli, Constantina Tsioufis, Costas Braunschweig, Frieder Dragioti, Elena Charitakis, Emmanouil Front Cardiovasc Med Cardiovascular Medicine BACKGROUND: Sudden cardiac death (SCD) is a global public health issue, accounting for 10–20% of deaths in industrialized countries. Identification of modifiable risk factors may reduce SCD incidence. METHODS: This umbrella review systematically evaluates published meta-analyses of observational and randomized controlled trials (RCT) for the association of modifiable risk and protective factors of SCD. RESULTS: Fifty-five meta-analyses were included in the final analysis, of which 31 analyzed observational studies and 24 analyzed RCTs. Five associations of meta-analyses of observational studies presented convincing evidence, including three risk factors [diabetes mellitus (DM), smoking, and early repolarization pattern (ERP)] and two protective factors [implanted cardiac defibrillator (ICD) and physical activity]. Meta-analyses of RCTs identified five protective factors with a high level of evidence: ICDs, mineralocorticoid receptor antagonist (MRA), beta-blockers, and sodium-glucose cotransporter-2 (SGLT-2) inhibitors in patients with HF. On the contrary, other established, significant protective agents [i.e., amiodarone and statins along with angiotensin-converting enzyme (ACE) inhibitors in heart failure (HF)], did not show credibility. Likewise, risk factors as left ventricular ejection fraction in HF, and left ventricular hypertrophy, non-sustain ventricular tachycardia, history of syncope or aborted SCD in pediatric patients with hypertrophic cardiomyopathy, presented weak or no evidence. CONCLUSIONS: Lifestyle risk factors (physical activity, smoking), comorbidities like DM, and electrocardiographic features like ERP constitute modifiable risk factors of SCD. Alternatively, the use of MRA, beta-blockers, SGLT-2 inhibitors, and ICD in patients with HF are credible protective factors. Further investigation targeted in specific populations will be important for reducing the burden of SCD. SYSTEMATIC REVIEW REGISTRATION: https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42020216363, PROSPERO CRD42020216363. Frontiers Media S.A. 2022-06-16 /pmc/articles/PMC9246322/ /pubmed/35783841 http://dx.doi.org/10.3389/fcvm.2022.848021 Text en Copyright © 2022 Tsartsalis, Korela, Karlsson, Foukarakis, Svensson, Anastasakis, Venetsanos, Aggeli, Tsioufis, Braunschweig, Dragioti and Charitakis. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Cardiovascular Medicine Tsartsalis, Dimitrios Korela, Dafni Karlsson, Lars O. Foukarakis, Emmanouil Svensson, Anneli Anastasakis, Aris Venetsanos, Dimitrios Aggeli, Constantina Tsioufis, Costas Braunschweig, Frieder Dragioti, Elena Charitakis, Emmanouil Risk and Protective Factors for Sudden Cardiac Death: An Umbrella Review of Meta-Analyses |
title | Risk and Protective Factors for Sudden Cardiac Death: An Umbrella Review of Meta-Analyses |
title_full | Risk and Protective Factors for Sudden Cardiac Death: An Umbrella Review of Meta-Analyses |
title_fullStr | Risk and Protective Factors for Sudden Cardiac Death: An Umbrella Review of Meta-Analyses |
title_full_unstemmed | Risk and Protective Factors for Sudden Cardiac Death: An Umbrella Review of Meta-Analyses |
title_short | Risk and Protective Factors for Sudden Cardiac Death: An Umbrella Review of Meta-Analyses |
title_sort | risk and protective factors for sudden cardiac death: an umbrella review of meta-analyses |
topic | Cardiovascular Medicine |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9246322/ https://www.ncbi.nlm.nih.gov/pubmed/35783841 http://dx.doi.org/10.3389/fcvm.2022.848021 |
work_keys_str_mv | AT tsartsalisdimitrios riskandprotectivefactorsforsuddencardiacdeathanumbrellareviewofmetaanalyses AT koreladafni riskandprotectivefactorsforsuddencardiacdeathanumbrellareviewofmetaanalyses AT karlssonlarso riskandprotectivefactorsforsuddencardiacdeathanumbrellareviewofmetaanalyses AT foukarakisemmanouil riskandprotectivefactorsforsuddencardiacdeathanumbrellareviewofmetaanalyses AT svenssonanneli riskandprotectivefactorsforsuddencardiacdeathanumbrellareviewofmetaanalyses AT anastasakisaris riskandprotectivefactorsforsuddencardiacdeathanumbrellareviewofmetaanalyses AT venetsanosdimitrios riskandprotectivefactorsforsuddencardiacdeathanumbrellareviewofmetaanalyses AT aggeliconstantina riskandprotectivefactorsforsuddencardiacdeathanumbrellareviewofmetaanalyses AT tsioufiscostas riskandprotectivefactorsforsuddencardiacdeathanumbrellareviewofmetaanalyses AT braunschweigfrieder riskandprotectivefactorsforsuddencardiacdeathanumbrellareviewofmetaanalyses AT dragiotielena riskandprotectivefactorsforsuddencardiacdeathanumbrellareviewofmetaanalyses AT charitakisemmanouil riskandprotectivefactorsforsuddencardiacdeathanumbrellareviewofmetaanalyses |